NasdaqGS:CMPSBiotechs
A Look At COMPASS Pathways (CMPS) Valuation After Phase 3 COMP360 Data And Priority Review Voucher
COMPASS Pathways (CMPS) stock is in focus after the company reported a Q1 2026 net income of US$91.2 million and basic earnings per share of US$0.71, reversing a loss a year earlier.
See our latest analysis for COMPASS Pathways.
The share price has been volatile, but the recent phase 3 data for COMP360 and the National Priority Voucher appear to be feeding into strong momentum. A 30 day share price return of 55.71% and a 1 year total shareholder return of 138.39% reflect how quickly sentiment...